CAVE CREEK, Ariz., May 30, 2013 /PRNewswire/ -- Endexx
Corporation (OTC PINK: EDXC) (http://www.endexx.com/) announced
today that it has entered into a definitive agreement to acquire
Dispense Labs, LLC. Dispense Labs has a sophisticated
inventory management system and client server-based dispensing
machine, known as Autospense (http://www.autospense.com/).
Autospense has applications to enhance the processes necessary to
provide M3Hub (http://www.m3hub.com/), a division of Endexx, with a
reliable and compliant medical marijuana management
solution.
"We are determined to provide the most dynamic and functional
medical marijuana management platform in the industry," said
Todd Davis, CEO of Endexx
Corporation. "We intend to work with Dispense Labs President
Joseph DeRobbio and his team to
maximize the availability of Autospense, the most technologically
advanced system to date that meets the needs of the medical
marijuana industry and patients. Acquiring Dispense Labs was a
strategic decision. As a result, we believe M3Hub is one step
closer to being the dominant player in this extremely challenging
market."
By incorporating sophisticated software, along with advanced
safety and security measures, Autospense is designed and
manufactured to dispense medical marijuana while also managing the
supply chain. It also provides up-to-the-minute accounting and
protects the security of the product, as well as the patient
accessing the system. The high-tech machines feature compliance,
tracking, accountability, inventory management and a secured client
server, all of which were requirements for the M3Hub platform.
"We are pleased to be working with M3Hub and Endexx," said
DeRobbio. "This acquisition gives Dispense Labs the capital
resources necessary to fulfill our go-to-market strategy. The
financial backing will allow us to respond to and meet industry
demand for Autospense. Endexx and Dispense Labs are aligned in a
shared vision of growth and sustainability. As a result, this
acquisition makes our plan executable. In addition, it gives us the
ability to migrate the technology into other business environments,
as it is an overall solution for a variety of industries."
Moving forward, Dispense Labs will be a division of Endexx
Corporation with DeRobbio as its president. Autospense,
co-developed by DeRobbio, recently completed its beta-testing
process. The technology solution is now being deployed into
the clinical market. For more information, please call
800-316-6071.
About Dispense Labs:
Comprised of forward-thinking
business leaders, healthcare advocates and technical experts,
Dispense Labs LLC is the innovator of Autospense, a fully automated
dispensing system that mitigates problems and concerns associated
with medical marijuana. Founded in 2009, the company provides
innovative solutions and sound business practices in support of
social, political, business, law enforcement and community
interests. For more information, please call 800-316-6071 or visit
www.autospense.com.
About Endexx:
Endexx Corporation is a micro-cap
publicly traded company, representing the interest of its
shareholders and collaborating with independent software
developers, scientists, engineers, and other companies to build
businesses that can thrive collectively in the equity markets.
Endexx's team recognizes that individually small companies with new
technologies have an extremely difficult time sustaining themselves
as stand-alone companies. Through our collaborative practices,
individual and group skill sets are better utilized to develop
technology and grow the business, while centralizing costs and
eliminating redundancies.
The Endexx management team and its advisory group each have at
minimum 10-50 years of experience in their respective fields. The
business professionals associated with the direction of the company
all have experience growing businesses, developing and implementing
new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a
platform for entrepreneurs to thrive, offering maximum return on
investment through equity ownership in the parent corporation. Each
individual is a shareholder and is encouraged and self-driven to be
successful and contribute to the overall objective of increasing
shareholder value.
Contact: Todd Davis at
Todd.Davis@endexx.com
Contact Endexx via email to receive corporate news and updates at
Endexx@endexx.com
http://www.otcmarkets.com/stock/EDXC/quote,
www.endexx.com
Safe Harbor Statement
This press release contains
forward-looking information within the meaning of Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), including statements regarding potential sales, the success
of the company's business, as well as statements that include the
word "believe" or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or
achievements of Endexx to differ materially from those
implied or expressed by such forward-looking statements. This press
release speaks as of the date first set forth above,
and Endexx assumes no responsibility to update the
information included herein for events occurring after the date
hereof. Actual results could differ materially from those
anticipated due to factors such as the lack of capital, timely
development of products, inability to deliver products when
ordered, inability of potential customer to pay for ordered
products, and political and economic risks inherent in
international trade.
Contact:
Todd Davis
Endexx Corporation
480-595-6900
Todd.Davis@endexx.com
Joseph DeRobbio
Dispense Labs, LLC
800-316-6071
SOURCE Endexx Corporation